Celgene Reports First Quarter 2017 Operating and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Celgene Reports First Quarter 2017 Operating and Financial Results

Celgene (CELG) Tops Q1 EPS by 4c; Raises Outlook

April 27, 2017 7:29 AM EDT

Celgene (NASDAQ: CELG) reported Q1 EPS of $1.68, $0.04 better than the analyst estimate of $1.64. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $3.04 billion.

Our significant first quarter operational, financial and strategic progress strengthen our confidence and outlook for 2017, said Mark J. Alles, Celgenes Chief Executive Officer. Our business momentum is increasing as we continue to generate meaningful catalysts and long-term value drivers.

Net Product Sales Performance

REVLIMID® sales for the first quarter increased 20 percent to $1,884 million. Sales growth was driven primarily by... More